Recruiting

Observational Study

Sponsor:

University of Texas Southwestern Medical Center

Code:

NCT01018537

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This project is based on the idea that we can learn about the complexities of MS by following disease and treatment patterns in a large group of people over several years. The information gathered is used for research only. Results are presented in summary form only. All details submitted by registry participants is strictly confidential.

To participate in NARCOMS complete the baseline enrollment survey online through www.narcoms.org (or directly using the following link: https://redcap.link/py2rnyyn) or you can request a mail-in survey be sent to you by emailing MSregistry@narcoms.org. You will be asked to update your information, online or by mail, twice a year. Each update survey typically takes less than 20 minutes to complete.

There is no cost to participate. For your participation you are offered a free subscription to the NARCOMS quarterly magazine, NARCOMS Now. NARCOMS Now provides a reliable source of information about the latest in MS research and disease management. You can stop participating in the registry at any time.

You may also receive additional surveys or information on clinical trials. You are not obligated to participate and these additional studies will always come directly from NARCOMS. Your contact information will not be shared or sold to other parties.

Conditions

Multiple Sclerosis

Study ID

NCT01018537

Start date

Jan, 1996

Status verified date

Nov, 2025

Completion date

Dec, 2050

Anticipated

Primary completion date

Dec, 2050

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Any individual who has been diagnosed with multiple sclerosis or clinically isolated syndrome
  • Must be at least 18 years of age

Exclusion Criteria:

  • None

Study Design

Enrollment

50000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Disease progression over time of follow up [ Time Frame: up to 15 years ]

Central Contacts and Locations

Central contacts

Locations

UT Southwestern Medical Center

Recruiting

Dallas, Texas, United States, 75390-8806

Contacts

Principal Investigator:

Amber Salter, Ph.D.

More Information

Sponsor

University of Texas Southwestern Medical Center

Last update posted

Nov 13, 2025

Last verified

Nov, 2025

Keywords

  • Multiple Sclerosis
  • NARCOMS
  • Patient Registry
  • Registry

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-18. This information was provided to ClinicalTrials.gov by University of Texas Southwestern Medical Center on 2025-11-13.